Numbers
The Numbers
Aether trades at 84x earnings because the market is pricing in a capex-to-revenue inflection that hasn't happened yet. Revenue is accelerating (TTM ₹1,094 Cr, +30% YoY), operating margins are expanding back to 33%, and the CEM pivot is real — but free cash flow has been negative every year of the company's existence, ROCE sits at 10%, and the stock needs to double its revenue base to justify today's price. The single metric most likely to rerate or derate this stock is site utilization at the new facilities: every 10 percentage points of utilization gain at Sites 3++/4/5 adds roughly 300–400 bps of operating leverage.
Current Price (₹)
Market Cap (₹ Cr)
Revenue TTM (₹ Cr)
OPM (TTM)
ROCE
EPS (TTM)
P/E
Quality Score, Fair Value, and predictability ratings are unavailable for this company. Analysis relies on reported financials and peer benchmarks.
Revenue & Earnings Power
Revenue scaled from ₹109 Cr (FY18) to ₹839 Cr (FY25) — a 34% revenue CAGR over 7 years — but the path was uneven: FY24 saw an 8% revenue decline and a 37% profit drop during the global specialty chemicals destocking cycle.
Margins recovered to near-peak levels in FY25 (29% OPM) and TTM has expanded further to 33% — the highest in Aether's history, driven by CEM mix shift and operating leverage as utilization climbs.
The quarterly trajectory is the bull case in one chart: revenue has climbed from ₹118 Cr (Q4 FY24 trough) to ₹317 Cr (Q3 FY26) — a 169% increase in 7 quarters.
Cash Generation — Are the Earnings Real?
Earnings are not converting to cash. Over FY22–FY25, Aether reported cumulative net income of ₹479 Cr but generated cumulative operating cash flow of just ₹72 Cr — a 15% conversion ratio. Working capital absorption (inventory build for new sites + long receivable cycles with MNC customers) is the primary drain.
Cumulative FCF over FY22–FY25: negative ₹1,316 Cr. Cumulative capex over the same period: ₹1,388 Cr. This is a company funding growth entirely through equity (IPO + QIP raised ~₹1,100 Cr) and modest debt. Until sites ramp and capex normalizes, there will be no cash returns for equity holders.
Balance Sheet Health
The balance sheet is clean. Debt-to-equity: 0.09x (nearly debt-free). The IPO (June 2022) and QIP (June 2023) transformed the capital structure — borrowings collapsed from ₹291 Cr to ₹16 Cr post-QIP, then crept back to ₹200 Cr as capex accelerated. Total assets more than tripled from ₹770 Cr to ₹2,644 Cr in 3 years, almost entirely from equity-funded capex.
The cash conversion cycle peaked at 429 days in FY24 — over 14 months of working capital tied up. It improved to 367 days in FY25, driven by faster collections (debtor days down from 142 to 126). Inventory days remain stubbornly high (356 days) due to raw material stocking for new site launches. Management guided 160 net working capital days as of Dec 2025.
Returns on Capital
ROCE tells the core story: pre-capex Aether earned 30%+ returns, but the asset base has tripled while revenue only doubled. ROCE bottomed at 7% in FY24 and is recovering (10% FY25). The critical question is whether ROCE can recover above 15–18% as sites fill up — that is the difference between value creation and capital destruction.
Valuation — Is the Market Price Justified?
P/E (FY25)
P/E (TTM)
Analyst Target (₹)
At ₹1,172, the stock trades at 72x TTM earnings — expensive by any absolute measure but compressed from the 133x peak during the FY24 trough when earnings collapsed. The P/E has declined not because the stock fell, but because earnings caught up. If the quarterly run rate (₹64 Cr PAT in Q3 FY26) annualizes, the forward P/E drops to ~46x.
The 5 analysts covering the stock have a mean target of ₹1,154 — essentially flat from current levels, implying the near-term re-rating has already happened.
EV/Revenue has compressed from 26x to 14x as revenue scales — still expensive but moving in the right direction.
Peer Comparison
Aether trades at the highest EV/Sales (18.6x) and P/E (84x) in the peer set, with the lowest ROCE (10%) and ROE (7.5%). The premium is a bet on future returns, not current ones. PI Industries — the closest business model comp — trades at 34x P/E with 23% ROCE and 5.8x EV/Sales. The gap implies the market expects Aether to deliver PI-level returns within 2–3 years.
Fair Value & Scenario
At ₹1,172, the stock is priced for the base case. Upside requires both revenue acceleration AND margin expansion — the bull path demands everything going right simultaneously (Sites 3++/5 ramp, CEM contracts fill, working capital normalizes).
The numbers confirm that Aether is a genuine growth story with expanding margins and an accelerating revenue trajectory. They contradict the idea that this is a high-quality compounder today — at 10% ROCE, chronic negative FCF, and 367-day cash conversion cycles, the financial quality metrics are middling at best. Watch ROCE recovery above 15% and the first quarter of positive free cash flow — those two events would signal that the heavy investment phase is yielding returns, and would justify the premium multiple.